Korean J Urol.  2001 Dec;42(12):1278-1283.

Assessing the Effect of Finasteride by Prostate Tissue Composition

Affiliations
  • 1Department of Urology, Chonnam National University Medical School, Gwangju, Korea. sbryu@chonnam. ac.kr

Abstract

PURPOSE: We determine whether the epithelial content of the prostate and prostate volume before treatment related to the effect of finasteride.
MATERIALS AND METHODS
Transrectal ultrasonography (TRUS) guided sextant biopsies of the prostate were obtained from 30 male subjects with symptomatic benign prostatic hyperplasia (BPH) prior to initiating therapy with finasteride. Anti-cytokeratine staining and computer-assisted quantitative color image analysis were utilized to quantify the area density of glandular epithelium, stroma and glandular lumen. The clinical response to finasteride was based upon changes in peak urinary flow rate (Qmax), post voiding residual urine (PVR), International Prostate Symptom Score (IPSS), serum prostate specific antigen (PSA) and prostate volume.
RESULTS
The average compositions among the 30 glands were as the following: epithelium 15.46.3%; stroma 75.3+/-8.6%; lumen 9.3+/-4.5%. The mean prostate volume was 52.0+/-25.3cc. Pretreatment epithelial content and pretreatment prostate volume had no relation with finasteride effect in Qmax, PVR, IPSS and PSA except in change of prostate volume. We found a linear correlation between pretreatment epithelial volume and finasteride-induced prostate volume reduction (p<0.01).
CONCLUSIONS
Finasteride-induced prostate volume reduction has a correlation with pretreatment epithelial volume.

Keyword

Finasteride; Benign prostatic hyperplasia; Image analysis

MeSH Terms

Biopsy
Epithelium
Finasteride*
Humans
Male
Prostate*
Prostate-Specific Antigen
Prostatic Hyperplasia
Ultrasonography
Finasteride
Prostate-Specific Antigen
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr